FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Medical Devices

Philips Hit With Rare 518(a) Order on Ventilators

After determining inadequate recall notifications to date, FDA issues a rare Section 518(a) notification order to Philips Respironics requiring the co...

Human Drugs

Hold Lifted on Immunome Covid Antibody Cocktail

FDA removes an Immunome clinical hold on its antibody cocktail (IMM-BCP-01) for treating Covid-19 after the company provided more therapy preparation ...

FDA General

Ex-Blackstone Sales Director Gets 51 Months Sentence

A federal judge sentences James Boccuzzi of Parkland, FL, a former sales director for Blackstone Labs, to 51 months in prison for conspiring to defrau...

Human Drugs

Venatorx Pharma Plans NDA for Infection Fighter

Venatorx Pharmaceuticals plans a fourth quarter NDA submission following positive results from its pivotal Phase 3 study evaluating cefepime-taniborba...

Human Drugs

FDA Sets PDUFA Target Date for Acadia Nuplazid sNDA

FDA says it will act on 8/4 on an Acadia Pharmaceuticals resubmitted sNDA for Nuplazid to treat hallucinations and delusions associated with Alzheimer...

Biologics

Judge Approves StemGenex Client Settlement

A California federal judge approves a $3.65 million settlement between the defunct StemGenex stem cell clinic and 1,063 former clients who said they w...

Human Drugs

Look Into PBM Competitive Concerns: Grassley

Sen. Charles Grassley calls on the Federal Trade Commission to overcome a deadlocked vote and initiate a study into the business practices of pharmacy...

Federal Register

Draft Guide on Drug Supplier Verification Systems

Federal Register notice: FDA makes available a revised draft guidance entitled Verification Systems Under the Drug Supply Chain Security Act for Certa...

Human Drugs

Zydus/Cadila Gets FDA-483 After Inspection

FDA issued Zydus Lifesciences (formerly known as Cadila Healthcare) a three-item Form FDA-483 after recently inspecting the firms Jarod, Gujarat (Indi...

Federal Register

Oncologic Panel Meeting to Review Ukoniq sNDA

Federal Register notice: FDA has announces a 4/21-22 Oncologic Drugs Advisory Committee meeting that will discuss the appropriate approach for phospha...